Post by
Jon9800 on Jun 22, 2022 9:52am
Hemostemix – company outlook & stock Insights
Hemostemix Inc. (TSX-V: $HEM) is a publicly-traded biotech company. Its principal business is developing, manufacturing, and commercializing innovative blood-derived stem cell therapies. The company has an overall market worth of 18M. Check out the further details over TSX-V. Click on the link below.
https://money.tmx.com/en/quote/HEM